Skip to main content

Advertisement

Log in

Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The purpose of this paper was to review our clinical experience in patients with osteomyelitis (OM) of the jaw, focusing on aspects of antimicrobial resistance. A retrospective review of the medical records of adult patients with jaw OM was carried out. Among 46 cases of jaw OM, the cause was odontogenic in 32 (seven had recent dental implants and four bisphosphonate osteonecrosis), postoperative/post-traumatic in eight, and secondary to osteoradionecrosis in six. Clinical features were chronic in 91.3%. The infection was polymicrobial in 24/41 (65.9%). Viridans streptococci were the most commonly isolated agents. Among 26 viridans streptococci tested, 81% were susceptible to penicillin and 96% to fluorquinolones, but only 11.5% to clindamycin. Overall, 35/38 (92.1%) had at least one clindamycin-resistant isolate. Appropriate antibiotics were administered for a mean of 5.8 ± 3.2 months. Beta-lactams were used in 19 cases and fluorquinolones in 14. Among 39 cases with long-term follow-up, only two relapsed. Currently, jaw OM is commonly related to osteoradionecrosis, dental implants, and bisphosphonates. In patients with prior antibiotics exposure, a high percentage of infections were caused by clindamycin-resistant microorganisms, thus, beta-lactams should be the antibiotic of choice. In penicillin-allergic cases, the new fluorquinolones, probably in combination with rifampin and/or clindamycin, could be a promising alternative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bieluch VM, Garner JG (1995) Osteomyelitis of the skull, mandible and sternum. In: Jauregui LE (ed) Diagnosis and management of bone infections. Marcel Decker, New York

    Google Scholar 

  2. Hudson JW (1993) Osteomyelitis of the jaws: a 50-year perspective. J Oral Maxillofac Surg 51:1294–1301

    Article  PubMed  CAS  Google Scholar 

  3. Calhoun KH, Shapiro RD, Stiernberg CM et al (1988) Osteomyelitis of the mandible. Arch Otolaryngol Head Neck Surg 114:1157–1162

    PubMed  CAS  Google Scholar 

  4. Adekeye EO, Cornah J (1985) Osteomyelitis of the jaws: a review of 141 cases. Br J Oral Maxillofac Surg 23:24–35

    Article  PubMed  CAS  Google Scholar 

  5. Schuknecht B, Valavanis A (2003) Osteomyelitis of the mandible. Neuroimaging Clin N Am 13:605–618. doi:10.1016/S1052-5149(03)00044-3

    Article  PubMed  Google Scholar 

  6. Marx RE (1991) Chronic osteomyelitis of the jaws. Oral Maxillofac Surg Clin North Am 3:367–381

    Google Scholar 

  7. Mercuri LG (1991) Acute osteomyelitis of the jaw. Oral Maxillofac Surg Clin North Am 3:355–366

    Google Scholar 

  8. Seto BG, Lynch SR, Moy PK (1986) Chronic osteomyelitis of mandible caused by penicillin-resistant Bacteroides ruminicola. Report of a case. Oral Surg Oral Med Oral Pathol 61:29–31. doi:10.1016/0030-4220(86)90198-2

    Article  PubMed  CAS  Google Scholar 

  9. Kuriyama T, Karasawa T, Nakagawa K et al (2001) Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 16:10–15. doi:10.1034/j.1399-302x.2001.160102.x

    Article  PubMed  CAS  Google Scholar 

  10. Ioannidou S, Tassios PT, Kotsovili-Tseleni A et al (2001) Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. Int J Antimicrob Agents 17:195–201. doi:10.1016/S0924-8579(00)00338-1

    Article  PubMed  CAS  Google Scholar 

  11. Aracil B, Miñambres M, Oteo J et al (2001) High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J Antimicrob Chemother 48:592–594. doi:10.1093/jac/48.4.592

    Article  PubMed  CAS  Google Scholar 

  12. Doern GV, Ferraro MJ, Brueggemann AB et al (1996) Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 40:891–894

    PubMed  CAS  Google Scholar 

  13. Luong N, Tsai J, Chen C (2001) Susceptibilities of Eikenella corrodens, Prevotella intermedia, and Prevotella nigrescens clinical isolates to amoxicillin and tetracycline. Antimicrob Agents Chemother 45:3253–3255. doi:10.1128/AAC.45.11.3253-3255.2001

    Article  PubMed  CAS  Google Scholar 

  14. Sobottka I, Cachovan G, Stürenburg E et al (2002) In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 46:4019–4021. doi:10.1128/AAC.46.12.4019-4021.2002

    Article  PubMed  CAS  Google Scholar 

  15. Mättö J, Asikainen S, Väisänen ML et al (1997) Role of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in extraoral and some odontogenic infections. Clin Infect Dis 25(Suppl 2):S194–S198

    Article  PubMed  Google Scholar 

  16. Tomás I, Alvarez M, Limeres J et al (2004) In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. Oral Microbiol Immunol 19:331–335. doi:10.1111/j.1399-302x.2004.00167.x

    Article  PubMed  Google Scholar 

  17. Limeres J, Tomás I, Alvarez M et al (2005) Empirical antimicrobial therapy for odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:263–264. doi:10.1016/j.tripleo.2004.12.019

    Article  PubMed  Google Scholar 

  18. Stefanopoulos PK, Kolokotronis AE (2004) The clinical significance of anaerobic bacteria in acute orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:398–408. doi:10.1016/j.tripleo.2004.01.016

    Article  PubMed  Google Scholar 

  19. Cierny G 3rd, Mader JT, Penninck JJ (2003) A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res 414:7–24

    Article  PubMed  Google Scholar 

  20. Triplett RG, Andrews JA, Hallmon WW (2003) Management of peri-implantitis. Oral Maxillofac Surg Clin North Am 15:129–138. doi:10.1016/S1042-3699(02)00078-X

    Article  PubMed  Google Scholar 

  21. Duncan JP, Nazarova E, Vogiatzi T et al (2003) Prosthodontic complications in a prospective clinical trial of single-stage implants at 36 months. Int J Oral Maxillofac Implants 18:561–565

    PubMed  Google Scholar 

  22. Sánchez-Garcés MA, Gay-Escoda C (2004) Periimplantitis. Med Oral Patol Oral Cir Bucal 9:S63–S74

    Google Scholar 

  23. Goodacre CJ, Bernal G, Rungcharassaeng K et al (2003) Clinical complications with implants and implant prostheses. J Prosthet Dent 90:121–132. doi:10.1016/S0022-3913(03)00212-9

    Article  PubMed  Google Scholar 

  24. Kourtis SG, Sotiriadou S, Voliotis S et al (2004) Private practice results of dental implants. Part I: survival and evaluation of risk factors—Part II: surgical and prosthetic complications. Implant Dent 13:373–385

    PubMed  Google Scholar 

  25. Shibli JA, Martins MC, Lotufo RF et al (2003) Microbiologic and radiographic analysis of ligature-induced peri-implantitis with different dental implant surfaces. Int J Oral Maxillofac Implants 18:383–390

    PubMed  Google Scholar 

  26. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117. doi:10.1016/S0278-2391(03)00720-1

    Article  PubMed  Google Scholar 

  27. Migliorati CA, Schubert MM, Peterson DE et al (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104:83–93. doi:10.1002/cncr.21130

    Article  PubMed  CAS  Google Scholar 

  28. Marx RE, Sawatari Y, Fortin M et al (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567–1575. doi:10.1016/j.joms.2005.07.010

    Article  PubMed  Google Scholar 

  29. Bartkowski SB, Zapala J, Heczko P et al (1998) Actinomycotic osteomyelitis of the mandible: review of 15 cases. J Craniomaxillofac Surg 26:63–67. doi:10.1016/S1010-5182(98)80037-1

    PubMed  CAS  Google Scholar 

  30. Tomás I, Alvarez M, López-Meléndez C et al (2005) In vitro activity of telithromycin against mefA and ermB erythromycin-resistant viridans streptococci isolated from bacteremia of oral origin in Spain. Oral Microbiol Immunol 20:35–38. doi:10.1111/j.1399-302X.2004.00169.x

    Article  PubMed  Google Scholar 

  31. Alós JI, Aracil B, Oteo J et al (2000) High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting. J Antimicrob Chemother 45:605–609. doi:10.1093/jac/45.5.605

    Article  PubMed  Google Scholar 

  32. Tamayo J, Pérez-Trallero E, Gómez-Garcés JL et al (2005) Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J Antimicrob Chemother 56:780–782. doi:10.1093/jac/dki286

    Article  PubMed  CAS  Google Scholar 

  33. Seppälä H, Klaukka T, Lehtonen R et al (1995) Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 21:1378–1385

    PubMed  Google Scholar 

  34. Romero Vivas J, Rubio Alonso M, Corral O et al (1997) Estudio de las infecciones respiratorias extrahospitalarias [Community-acquired respiratory infections]. Enferm Infecc Microbiol Clin 15:289–298

    PubMed  CAS  Google Scholar 

  35. Lo Bue AM, Sammartino R, Chisari G et al (1993) Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections. J Antimicrob Chemother 31(Suppl E):S119–S127

    Google Scholar 

  36. Gilbert DN, Moellering RC, Eliopoulus GM et al (2007) The Sanford guide to antimicrobial therapy, 37th edn. Antimicrobial Therapy, Inc., Sperryville, VA

    Google Scholar 

  37. Flynn TR, Halpern LR (2003) Antibiotic selection in head and neck infections. Oral Maxillofac Surg Clin North Am 15:17–38. doi:10.1016/S1042-3699(02)00082-1

    Article  PubMed  Google Scholar 

  38. Sharkawy AA (2007) Cervicofacial actinomycosis and mandibular osteomyelitis. Infect Dis Clin North Am 21:543–556. doi:10.1016/j.idc.2007.03.007

    Article  PubMed  Google Scholar 

  39. Milazzo I, Blandino G, Musumeci R et al (2002) Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int J Antimicrob Agents 20:451–456. doi:10.1016/S0924-8579(02)00190-5

    Article  PubMed  CAS  Google Scholar 

  40. Huddleston PM, Steckelberg JM, Hanssen AD et al (2000) Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 82:161–173

    PubMed  CAS  Google Scholar 

  41. Perry AC, Prpa B, Rouse MS et al (2003) Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 414:95–100. doi:10.1097/01.blo.0000087322.60612.14

    Article  PubMed  Google Scholar 

  42. Mäkinen TJ, Veiranto M, Lankinen P et al (2005) In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 56:1063–1068. doi:10.1093/jac/dki366

    Article  PubMed  CAS  Google Scholar 

  43. Rodríguez-Avial I, Rodríguez-Avial C, Culebras E et al (2007) Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain. Int J Antimicrob Agents 29:478–480. doi:10.1016/j.ijantimicag.2006.12.006

    Article  PubMed  CAS  Google Scholar 

  44. Collin BA, Leather HL, Wingard JR et al (2001) Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33:947–953. doi:10.1086/322604

    Article  PubMed  CAS  Google Scholar 

  45. Laskin DM (2003) The use of prophylactic antibiotics for the prevention of postoperative infections. Oral Maxillofac Surg Clin North Am 15:155–160. doi:10.1016/S1042-3699(02)00067-5

    Article  PubMed  Google Scholar 

  46. Esposito M, Coulthard P, Oliver R et al (2003) Antibiotics to prevent complications following dental implant treatment. Cochrane Database Syst Rev (3):CD004152

  47. Little JW, Falace DA, Miller CS et al (2008) Antibiotic prophylaxis in dentistry: an update. Gen Dent 56:20–28

    PubMed  Google Scholar 

Download references

Acknowledgments

We thank Celine Cavallo for the English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Pigrau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pigrau, C., Almirante, B., Rodriguez, D. et al. Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure. Eur J Clin Microbiol Infect Dis 28, 317–323 (2009). https://doi.org/10.1007/s10096-008-0626-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-008-0626-z

Keywords

Navigation